HeartWare International (HTWR) vs. Its Peers Head to Head Contrast

HeartWare International (NASDAQ: HTWR) is one of 19 public companies in the “Medical Devices & Implants” industry, but how does it contrast to its rivals? We will compare HeartWare International to similar businesses based on the strength of its dividends, institutional ownership, analyst recommendations, risk, profitability, earnings and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for HeartWare International and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HeartWare International 0 0 0 0 N/A
HeartWare International Competitors 126 738 1041 10 2.49

As a group, “Medical Devices & Implants” companies have a potential upside of 40.55%. Given HeartWare International’s rivals higher probable upside, analysts plainly believe HeartWare International has less favorable growth aspects than its rivals.

Profitability

This table compares HeartWare International and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
HeartWare International -15.84% -25.32% -10.14%
HeartWare International Competitors -100.14% -92.44% -29.75%

Valuation & Earnings

This table compares HeartWare International and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
HeartWare International N/A N/A -17.05
HeartWare International Competitors $1.67 billion $207.76 million 56.75

HeartWare International’s rivals have higher revenue and earnings than HeartWare International. HeartWare International is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

54.4% of shares of all “Medical Devices & Implants” companies are held by institutional investors. 10.3% of shares of all “Medical Devices & Implants” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

HeartWare International rivals beat HeartWare International on 5 of the 8 factors compared.

HeartWare International Company Profile

Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.

Receive News & Ratings for HeartWare International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartWare International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply